Related references
Note: Only part of the references are listed.The potential utility of [68 Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent-comparison with [18F]FDG
Lianjun Lan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings
Haojun Chen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study
Ximin Shi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas
Manuel Roehrich et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
68Ga-FAPI-46 PET/MR Detects Recurrent Cholangiocarcinoma and Intraductal Papillary Mucinous Neoplasm in a Patient Showing Increasing CEA with Negative 18F-FDG PET/CT and Conventional CT
Dheeratama Siripongsatian et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Role of [68Ga]Ga-DOTA-FAPI-04 PET/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET/CT
Liang Zhao et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Comparison of( 68)Ga-FAPI and F-18-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers
Yizhen Pang et al.
RADIOLOGY (2021)
Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients
Frederik L. Giesel et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
68Ga-FAPI-PET/CT in patients with various gynecological malignancies
Katharina Dendl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Clinicopathologic and Prognostic Significance of Gallbladder and Cystic Duct Invasion in Distal Bile Duct Carcinoma
Sun-Young Jun et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer
Haojun Chen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Comparison of magnetic resonance imaging and 18-fludeoxyglucose positron emission tomography/computed tomography in the diagnostic accuracy of staging in patients with cholangiocarcinoma A meta-analysis
Xujian Huang et al.
MEDICINE (2020)
68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
Frederik L. Giesel et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Diagnostic accuracy of 18F-FDGPET/CT for detection of peritoneal carcinomatosis; a systematic review and meta-analysis
Seong-Jang Kim et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation
Kim Sivesgaard et al.
EUROPEAN RADIOLOGY (2018)
A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
Anastasia Loktev et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Cholangiocarcinoma
Michela Squadroni et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
PET or PET/CT for Detection of Peritoneal Carcinomatosis A Meta-Analysis
Ming-Che Chang et al.
CLINICAL NUCLEAR MEDICINE (2013)
Diagnostic Value of FDG-PET for Lymph Node Metastasis and Outcome of Surgery for Biliary Cancer
Shogo Kobayashi et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
Clinical diagnosis and staging of cholangiocarcinoma
Boris Blechacz et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
The role of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma
Chang Mo Moon et al.
SURGICAL ONCOLOGY-OXFORD (2011)
FDG PET in the diagnosis of hilar cholangiocarcinoma
A Fritscher-Ravens et al.
NUCLEAR MEDICINE COMMUNICATIONS (2001)
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma
WR Jarnagin et al.
ANNALS OF SURGERY (2001)
Gallbladder cancer: Comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention
Y Fong et al.
ANNALS OF SURGERY (2000)